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Flotation tanks provide a unique environment for reducing the deleterious effects of 
stress on the human mind and body. As a result, biosensors capable of collecting 
objective physiological data during float sessions are needed to identify and quantify the 
resulting health effects. This thesis presents the selection and validation of off-the-shelf 
biosensors to investigate the physiological stress-reducing effects induced by this novel 
healthcare environment. The demands of the float environment required the biosensors 
to be wireless, waterproof, salt-proof, and minimally invasive. Interface and design 
modifications were made to the selected devices to ensure reliable operation in the 
unique conditions created by float tanks, and these modifications were tested for 
effectiveness in protecting the sensors, maintaining signal integrity, and reducing all 
forms of external sensory input that may detract from the float experience. As a result of 
the validation process, it was determined that the modified biosensors were capable of 
successfully recording movement, electrocardiograph (ECG), respiration, 
electroencephalograph (EEG), and blood pressure during float sessions. 
 
This thesis also investigated time synchronization and the analyses of biosensor outputs 
as they pertain to float research. A method to ensure time synchronization among 
sensors was developed and tested against an industry-leading physiological recording 
device to verify the accuracy of the biosensors’ timestamps. Additional experiments 
among sensors were conducted to further validate the technique and illustrate that a 
transient event can be identified across multiple data streams. A neural network was 
xi 
designed to facilitate the calculation of cardiac metrics such as heart rate and heart rate 
variability, and the results were analyzed to determine which methods provide the most 
useful information for float research. Data obtained from two accelerometer devices 
was also examined to determine optimal cut-points for classifying movement within the 
float tank, and measures of stillness and avoidance behavior were characterized. The 
proposed biosensors and methods were found to reliably and accurately measure 
changes in physiological variables during float sessions. This thesis documents the first 
successful implementation of collecting continuous physiological data during the float 
experience.
1 
Chapter 1: Introduction 
 
Float tanks, also referred to as isolation tanks, are lightless, soundproof tanks in which 
people float effortlessly in a dense salt water solution warmed to skin temperature. This 
unique environment reduces external sensory input (including visual, auditory, tactile, 
proprioceptive, and thermal sensory input) and is often described as sensory 
deprivation; however, this term can be misleading. Although float tanks reduce external 
sensory input, they often enhance internal sensory input, especially signals arising from 
the heart and respiration. This creates a peaceful meditative environment that naturally 
induces a state of relaxation. Objectively measuring this relaxation response has 
remained elusive, and past flotation research has failed to identify biosensors capable of 
recording signals in this unique environment. 
 
Float tanks come in various sizes and designs, but the basic components are the same. 
The two tanks used in this study are depicted in Figures 1 and 2 (Floataway, Norfolk, 
UK). Each circular pool is 2.5 m in diameter and contains roughly 1.25 kL of water 
mixed with 900 kg of Epsom salt (magnesium sulfate). This dense solution allows a 
person to float near the surface when in a supine position. The air in the rooms and 
water in the tanks are heated to skin temperature (34.5 oC), and the rooms in which the 
tanks are built are soundproof and devoid of light. These aspects of floating are 
responsible for the aforementioned reduction of external sensory input. 
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Research involving float tanks and sensory deprivation began in the 1950s but lacked 
technology capable of thoroughly investigating the resulting health effects [1], [2]. As a 
result, the field has remained relatively stagnant for the past half-century. The recent 
development of easy-to-use biosensors and the increased popularity of recreational 
floating have driven researchers and float tank entrepreneurs desiring to promote their 
businesses to revisit this topic of study. Early float research revealed that this 
therapeutic experience lowers levels of stress [3], [4], anxiety [5]–[7], and blood 
pressure [8], [9]. Today, people anecdotally report that floating alleviates chronic pain, 
depression, and eating disorders. Such reports have prompted business owners to add 
float tanks to their existing spa facilities, and clinical neuropsychologists are 
experimenting with float tanks as a type of therapy for reducing the negative effects of 
stress and anxiety.  
 
Since floating is returning as a form of treatment in a number of recreational and 
healthcare settings, biosensors that collect empirical data and examine float therapeutics 
are essential for accurately quantifying the resulting effects. Given the float tank’s 
unusual conditions, such devices must be waterproof and noncorrosive in the presence 
of salt. Furthermore, since floating is intended to minimize external sensations, devices 
must be minimally invasive and free of wires and attachments when possible. A form of 
wireless, real-time data transmission and viewing is also often desired to monitor 




Figure 1.  Open Float Tank 
 
 
Figure 2.  Enclosed Float Tank 
 
The objective of this thesis was to select and validate biosensors and their outputs for 
the study of float research. This involved: 
• Using selection criteria to select and modify devices. 
• Validating the general usability of devices in the float environment. 
• Analyzing device outputs to develop optimal metrics for float research. 
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For the selection of devices, off-the-shelf biosensors were chosen opposed to custom-
made devices available only to research institutes. Using readily available devices 
facilitates collaboration between researchers and float businesses where the increased 
resources of the businesses can be utilized to conduct studies on a larger scale. The 
selected devices in this study collect movement, electrocardiogram (ECG), respiration, 
electroencephalogram (EEG), and blood pressure data. Many of the wearable biosensors 
available to the public do not meet requirements necessitated by the float tank 
environment, so this thesis developed simple design modifications that can be easily 
implemented by other researchers and entrepreneurs alike.  
 
Following the modification process, initial testing was performed to determine the 
devices’ suitability and usefulness in float research. Various experiments were 
conducted to ensure that the biosensors operate in the float environment without 
experiencing physical damage or loss of data. Other tests investigated whether or not 
the proposed modifications altered the output of a device. The biosensors were also 
validated as a system. Protocols and tools for synchronizing devices were developed 
and analyzed to determine how data from separate devices can be compared. 
 
A comprehensive study of the devices’ outputs was then performed once the biosensors 
had been validated. Various cardiac metric algorithms and methods were analyzed to 
determine how to provide full access to the most useful information for float research. 
Devices that record movement data were compared to identify redundant information, 
and cut-points were optimized to classify movement. 
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The following list summarizes the contributions of this thesis: 
• Identified selection criteria and utilized it to select off-the-shelf biosensors for 
float research. 
• Developed easily reproducible modifications to devices to prevent physical 
damage, data loss, and excessive sensory input. 
• Validated the ability of each device to collect usable data during float sessions 
and characterized the effects that modifications have on the data. 
• Constructed a method of time synchronizing biosensors to enable the 
comparison of data from separate devices. 
• Designed a neural network to automatically detect R-peaks in ECG data. 
• Compared various cardiac metrics to determine which algorithms provide the 
most useful information for float research. 
• Analyzed data from multiple movement-tracking devices to identify 
redundancies and create cut-points for classification of movement. 
• Defined stillness and avoidance behavior to facilitate the study of movement. 
 
The remainder of this thesis is organized as follows. Chapter 2 presents an overview of 
related work. Chapter 3 details the biosensor selection and modification processes, 
along with validation of the usability of devices in the float environment. The 
instrumentation setup and time synchronization procedures are described in Chapter 4. 
Chapter 5 describes the neural network and provides an analysis of cardiac metrics and 
algorithms, identifying which are most useful for float research. Movement-tracking 
devices are compared in Chapter 6 to determine redundant devices and develop cut-
6 
points for accurate classification of movement. Chapter 7 offers a conclusion of the 
thesis and provides directions for future research. 
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Chapter 2: Related Work 
 
The work presented in this thesis built upon existing float studies and research 
involving the testing of devices and their outputs. This chapter presents an overview of 
related work and discusses physiological monitoring, various validation methods, and 
time synchronization. 
 
Previous float studies implemented measurement devices to examine the physiological 
effects of floating. The most common variable recorded was blood pressure. In an 
attempt to capture long-term effects, Fine et al. measured blood pressure prior to float 
sessions and in follow-up appointments [8]. Others [9]–[14] recorded blood pressure 
before and after each float to capture immediate results. In [15], [16], the authors 
collected blood pressure data only on non-float days, and another study measured blood 
pressure three times a day during the entire course of the experiment [17]. The literature 
certainly reveals that floating can decrease blood pressure, but no studies have 
attempted to monitor blood pressure continuously throughout the duration of float 
sessions. Thus, the changes that occur to blood pressure during the course of a float 
session are still largely unknown. 
 
Another common physiological variable studied in early float research is ECG. In [5], 
Forgays et al. used electrodes wired to a Narco Bio-Systems FM-1100 E2 transmitter 
and a matching biotelemetry FM-1100-7 receiver to record ECG before, after, and 
during float sessions; however, the authors discarded 30% of the data due to signal loss. 
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In a later study, they recorded ECG only before and after the float sessions [18]. In his 
master’s thesis, Steel successfully recorded ECG during floats to examine changes in T-
wave amplitude and heart rate [19]. He also tried to measure EMG but lost the data due 
to low signal-to-noise ratio. The authors of [20] measured heart rate before and after 
knee exercises and float sessions but not during the float sessions themselves. 
 
A few researchers recorded EEG during float sessions. One study used electrodes 
covered with a “mighty dry” diaper and surgical cap to continuously measure EEG 
without signal loss [21]. Fine et al. employed an Autogen 120 EEG device with wired 
electrodes to record average frequency, average amplitude, and percent time in filter 
range [22]. One electrode was placed on the forehead, while the other two were attached 
to nasal cartilage. 
 
Forgays et al. also measured breathing rate and frontalis muscle movement, but no 
analysis was presented [5]. No studies have thoroughly investigated the effects of 
floating in regards to breathing rates and body movement. 
 
Most wireless and mobile health sensors have gone through clinical testing to receive 
certification and FDA approval. When modifications are made to these devices to 
ensure compatibility with the float environment, additional validation is necessary. The 
Association for the Advancement of Medical Instrumentation (AAMI) often develops 
standards used in clinical validation. The standards stipulate test conditions, number of 
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subjects, and pass-fail criteria [23]–[25]. Such protocols can be adapted to validate 
modified devices. 
 
Other health devices, such as accelerometers that measure movement, do not require 
clinical validation. Instead, researchers often compare them to other devices or 
reference measures to determine accuracy. In [26], Esliger et al. used a mechanical 
shaker, a metabolic gas analyzer, and two additional accelerometers to validate the 
device under study. Using the shaker, they oscillated the accelerometers at specific 
frequencies and amplitudes and calculated standard deviation, coefficient of variation, 
and the Pearson product-moment correlation to determine the validity and reliability of 
the raw acceleration values. They then employed the gas analyzer to measure VO2 
during graded exercise, which was used to compute Pearson product-moment 
correlations for each accelerometer. Receiver-operator curves (ROC) were then 
analyzed to determine optimal cut-points to accurately classify activity levels using the 
accelerometers. The authors of [27] later tested these cut-points, again making use of 
oxygen uptake measurements for the analysis. 
 
Another study similarly compared two accelerometers by oscillating them with an 
orbital shaker [28]. The authors took this work a step further by developing models to 
classify activity levels from acceleration values. They attempted to train the models 
using data from one accelerometer and then apply them to data from the other. 
Classification accuracy decreased significantly when models were applied to data from 
a different device. 
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In the same way that movement-based metrics are often studied instead of raw 
acceleration values, cardiac metrics are analyzed to ensure accuracy and determine their 
meanings. In [29], heart rate variability (HRV) is defined along with various methods 
used to calculate it. The authors explain the aspects of HRV that each method 
emphasizes and propose guidelines for ensuring accurate HRV determinations. Such an 
analysis is necessary in float research to ensure the acquisition of metrics that yield the 
most useful information. 
 
Validating devices and their operation as a system greatly depends on time 
synchronization. For slow-changing physiological variables, it may be sufficient to use 
local timestamps to compare data between devices. For other variables, a more precise 
method is required. When the device being used is connected to the Internet, the 
Network Time Protocol (NTP) described in [30] ensures the precise time 
synchronization necessary when dealing with fast-changing variables. An NTP server 
regularly synchronizes clocks in its network to within a few milliseconds of 
Coordinated Universal Time (UTC).  
 
Unfortunately, many mobile health devices are not connected to an NTP server. These 
devices synchronize their real-time clocks (RTCs) to a computer when connected, but 
the RTCs have only one-second precision. Synchronizing these clocks with greater 
precision usually requires injecting a common signal into each data stream. Such a 
process is described in [31] by BIOPAC, a leader in the physiological data acquisition 
industry. BIOPAC injects a digital signal into its data streams in order to synchronize 
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stimulus presentations with multiple response recordings. Float research requires a 




Chapter 3: Selection and Modification of Devices 
 
The process of choosing biosensors for use in float research began with defining 
selection criteria. This chapter details these criteria and the resulting procedures used 
for selecting and modifying devices. This work focused on biosensors that monitor 
movement, ECG, respiration, EEG, and blood pressure since these measures are strong 
indicators of relaxation and are commonly studied in the literature. Each selected device 
was tested to determine its usability in the float environment. 
 
3.1 Selection Criteria 
 
The conditions of the float experience impose unique requirements on physiological 
devices used in float research. Float tanks contain an extremely dense salt-water 
solution and allow participants to float around unrestrained. The purpose of the 
environment is to reduce external sensory input. Based upon these characteristics, 
biosensors utilized in float research must be: 
• Waterproof 
• Non-corrosive in the presence of salt 
• Free of wires and attachments 
• Minimally invasive in terms of auditory, visual, and tactile stimulation 
In addition to these requirements, it is desirable for the devices to provide real-time data 
streaming to enable participant monitoring and provide biofeedback during float 
experiments. Unfortunately, few off-the-shelf devices meet these criteria. Devices that 
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meet these standards the closest must be identified and then modified to overcome their 
limitations. After reviewing various biosensors on the market, devices were selected for 
validation according to the selection criteria. 
 
3.2 The Kinect 
 
The Kinect (Microsoft, Redmond, WA) was initially chosen as the primary method of 
monitoring movement. The Kinect uses an infrared (IR) camera to noninvasively obtain 
depth images even in the absence of light, and the images are decomposed to provide 
skeleton joint points as xyz-coordinates [32]. The Kinect has been successfully used to 
analyze gait biometrics [33] and to track head motion [34]. It can be mounted above the 
float tank to avoid water damage, and it does not introduce any auditory or tactile 
stimuli into the float environment. The Kinect comes with many sample apps that allow 
users to display incoming RGB, depth, and skeletal data in real-time. Microsoft also 
provides a free software development kit (SDK) to create custom apps. For this work, 
the SDK was used to develop a Windows Forms application that displays joint points as 
a connected skeleton. The app also calculates the number of limb movements and the 
amount of time spent moving as illustrated in Figure 3. Since subjects usually float 
without clothing, the Kinect’s RGB data stream is disabled to protect participant 




Figure 3.  Kinect App to Monitor Movement 
 
The Kinect’s limitations are that the IR light is visible to the human eye and skeleton 
tracking does not work when a participant is upside down. A spectrum analyzer 
revealed that the IR light has a single wavelength of 830 nm, meaning that filters would 
completely block the light and prevent motion detection. As an alternative solution, the 
Kinect was covered with a clear dome, and pairs of magnets were placed on each side 
of the dome as illustrated in Figure 4. Magnets on the outside of the dome are held in 
place by magnets on the inside of the dome, and they can slide to any position to block 
the IR light from a participant’s view without negatively affecting movement tracking. 
In order for this method to work, a foothold system must be used to keep participants in 
a constant position. This is physically invasive but ultimately prevents participants from 
rotating in the tank and ensures that skeletal data can be collected. Certain float 
experiments require a constant head position anyway, so the Kinect can be employed in 




Figure 4.  Dome and Magnet System Used to Block IR Light 
 
The Kinect was tested with three subjects to validate its usability in the float 
environment. It was mounted above the closed float tank and covered with the dome 
system previously described, and the devised foothold system was employed to place 
the participant’s head in a specific location to block the IR light from view. Notably, the 
foothold system can be adjusted in one inch increments, and the magnets can slide 
anywhere on the dome to ensure the IR light is blocked from view for participants of 
various heights. 
 
After positioning a participant, the skeleton tracking application was initialized, and 
data collection commenced. The Kinect locates an individual based on his or her 
distance from the background, so it had difficulty distinguishing an individual’s body 
from the water in the tank. To remedy this, participants were instructed to lift their arms 
out of the water towards the camera while at the same time moving their legs back and 
forth. These movements created distance between the subject and the water and aided 
the Kinect in locating the participant, and the app successfully displayed the resulting 
skeleton. Alternatively, the Kinect can be switched from default mode to seated mode. 
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This causes the Kinect to track only the upper body and uses movement to initially 
locate the participant instead of distance. Experimental results revealed that tracking in 
seated mode results in quicker detection. After being located, the participants were 
asked to move their limbs to specific positions to test whether or not the skeleton 
accurately reflected those positions. The skeleton mirrored all three participants’ 
movements without ever losing their locations. 
 
The Kinect was also tested without using the foothold, dome, and magnets. As 
mentioned previously, the Kinect was unable to accurately track someone upside down. 
If a participant floats into this position, the displayed skeleton becomes severely 
disfigured until the participant returns to the upright position. When floating without the 
dome and magnets, the three participants stated that the IR light was not noticeable as 
long as their eyes were closed. The proposed modifications can be implemented flexibly 
to align with various experimental designs. 
 
3.3 GENEActiv Original Accelerometers 
 
As a second tool for tracking limb movements, the GENEActiv Original accelerometer 
(GENEActiv, Cambridgeshire, UK) was selected. This device records raw acceleration 
in the xyz-directions and is waterproof. It can be somewhat invasive, especially to 
participants not accustomed to wearing wristwatches, but is a good alternative to the 
Kinect when movement data is needed for an entire float session that does not use the 
17 
foothold system. The device stores data locally and cannot transmit wirelessly. No 
modifications were made to this device. 
 
GENEActiv accelerometers were shown to be both reliable and valid in [26], [28]. To 
begin validating the devices in float tanks, 11 participants wore a GENEActiv 
accelerometer on each wrist during 2 90-minute floats. These experiments confirmed 
that the watches are not damaged by the salt solution and are waterproof. The collected 
data reflected movement occurring within the float sessions as depicted in Figure 5, and 
Chapter 4 presents some of this data as it pertains to time synchronization. Also, 
Chapter 5 uses this data as a reference to develop cut-points for another device. Initial 




Figure 5.  One Subject’s Acceleration During a 90-minute Float Session 
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3.4 The BioPatch 
 
The BioPatch (Medtronic, Fridley, MN) consists of a small physiological monitoring 
module that attaches to the chest using standard ECG electrodes. It records ECG and 
breathing waveforms without the use of a chest strap by implementing a novel and 
proprietary measure of impedance, making it much less invasive than similar devices on 
the market. It also measures acceleration, posture, and skin temperature. The BioPatch 
stores data locally and can transmit one-second vitals via Bluetooth for real-time 
monitoring. The BioHarness, a similar device produced by the same company, uses a 
chest strap with embedded electrodes to measure the same variables. The validity and 
reliability of the BioHarness were proven in [35]–[37], and the results are applicable to 
the BioPatch since it uses the same algorithms. 
 
Although a participant’s chest usually remains above the water in a float tank, certain 
movements can cause the salt solution to reach the BioPatch electrodes and ruin the 
signal. The recent development of hydrophobic carbon electrodes that provide clean 
ECG signals in water-immersed conditions could easily solve this problem [38], but the 
BioPatch itself is not waterproof. Thus, Tegaderm (3M Healthcare Ltd., Loughborough, 
UK) is used to cover the BioPatch and prevent signal loss and physical damage in 
worst-case scenarios. The BioPatch also has flashing lights that must be covered with 
tape to ensure the device does not provide unwanted visual stimulation to participants. 
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To determine whether or not the BioPatch can record a usable ECG signal in the float 
environment, it was tested with 21 subjects during 90-minute float sessions. In all 21 
tests, the BioPatch successfully recorded ECG without signal loss or physical damage. 
A valuable characteristic of the BioPatch software is that it displays a heart rate 
confidence value between 0 and 100 in real time to signify whether or not the ECG 
signal is corrupted. As part of this study’s protocol, it is required that the heart rate 
confidence value reaches 100 before a participant can begin the float session, and the 
value is monitored as the participant enters the tank. When necessary, a participant can 
be asked to exit the tank and readjust the BioPatch and Tegaderm if the confidence 
value drops. In this way, it is ensured that the BioPatch successfully records ECG. An 
example signal taken from the end of a 90-minute float is depicted in Figure 6. 
 
 
Figure 6.  BioPatch ECG Signal at End of 90-minute Float Session 
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Along with ECG, the BioPatch successfully recorded posture, acceleration, skin 
temperature, and breathing rates during the 21 float sessions. The posture data is 
presented in Chapter 4 to illustrate time synchronization and event identification. 
Chapter 5 analyzes the acceleration data to determine optimal cut-points for movement 
classification. 
 
The accuracy of the BioPatch’s breathing rate values was evaluated in an additional 
experiment. A metronome was set to rates between 3 and 30 beats per minute, and 
participants were instructed to match their breathing to the rhythm while floating. When 
participants were able to sustain a breathing rate of 4 breaths per minute, the BioPatch 
accurately detected it as revealed in Table 1. Some participants were not able to 
maintain the lower breathing rates for the entire test duration. For those who did, the 
BioPatch was able to distinguish between most breathing rates between 4 and 30 
breaths per minute. Since this covers the typical breathing values expected in float 
research, it was determine that the BioPatch is a valid biosensor to monitor breathing 








Table 1.  BioPatch Breathing Rates while Floating 
Metronome Rate 
(Beats per Minute) 
Average Breathing Rate 













3.5 The QardioArm 
 
After a testing a few different blood pressure devices, the QardioArm wireless blood 
pressure monitor (Qardio, Inc., San Francisco, CA) was selected to measure blood 
pressure and heart rate. This device uses Bluetooth Smart, which performs well when 
establishing and maintaining connections. The QardioArm pairs with and is controlled 
by a smart phone or tablet. After a measurement is taken, the controlling device stores 
the data locally and also uploads the information to a cloud server. Data can be 
downloaded as either a CSV or Excel file, and then loaded into an external application 
for further analysis. The QardioArm is smaller and quieter than other blood pressure 
monitors and stays powered on for 15 minutes before automatically shutting off. Other 
devices turn off within two to five minutes. 
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The QardioArm is not waterproof and thus cannot survive in the float environment. To 
solve this issue, LimbO cast protectors (Thesis Technology, Hampshire, UK) designed 
to keep arm and leg casts dry when an individual is taking a shower or swimming in a 
pool were purchased. The LimbO cast protector is placed over the blood pressure device 
and participant’s arm to create a watertight seal as shown in Figure 7. The QardioArm’s 
smaller size again offers a benefit in that it can more easily fit into the LimbO without 
applying additional pressure to a participant’s arm. 
 
 
Figure 7.  LimbO Cast Protector 
 
The QardioArm was clinically validated according to [23], [24], so initial tests were 
aimed at determining whether or not the device could survive in the float environment 
and maintain its Bluetooth connection. For 3 subjects, the device was triggered at 10-
minute intervals. The QardioArm successfully provided blood pressure and heart rate 
data at each interval during the float sessions, and the LimbO prevented water from 
damaging the device. Participants also reported that the Qardio Arm felt less invasive 
due to its smaller size. 
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A study in the literature compared the QardioArm to other smartphone compatible 
blood pressure monitors and found that the QardioArm’s mean diastolic blood pressure 
was 3.955 mmHg higher than that of one of the other devices [39]. Other differences 
were not statistically significant, and no standard reference device was used. To further 
investigate these mean differences and determine whether the LimbO cast protector 
adds to them, the QardioArm was tested against a reference device with 12 subjects. For 
each subject, six measurements were taken with the QardioArm, the QardioArm 
covered with a LimbO, and the CASMED 740 Select (CAS Medical Systems, Inc., 
Branford, CT) for a total of 18 measurements per subject. Each participant was given a 
five-minute rest period before measurements began, and the order of devices was 
selected to produce two tests for each of the six possible orders. One minute of rest was 
given between each measurement, and six measurements were taken with one device 
before switching to the next device.  
 
As Figure 8 reveals, the QardioArm’s mean systolic blood pressure was 5.723 mmHg 
higher than the reference device, and this difference increased to 7.250 mmHg when 
using the LimbO cast protector. For mean diastolic blood pressure, the QardioArm 
measured 1.611 mmHg higher than the reference without the LimbO and 4.000 mmHg 
higher with the LimbO. The standard deviation of systolic blood pressure was 7.708, 
9.979, and 7.345 mmHg for the QardioArm with LimbO, QardioArm without LimbO, 
and reference device, respectively. For diastolic blood pressure, the standard deviations 
were 8.179, 9.157, and 6.455 mmHg. This suggests that the QardioArm is best suited 
for measuring blood pressure differences instead of raw values. The differences in 
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average values mean that the QardioArm should not be used to group participants into 
hypertension categories, but the similar standard deviations mean that the QardioArm 
should measure changes in blood pressure values as effectively as the reference device. 
Thus, the QardioArm can be used to compare blood pressure differences throughout and 













Figure 8.  Average Systolic Blood Pressure for 12 Subjects 
 
 
Figure 9.  Average Diastolic Blood Pressure for 12 Subjects 
 
The heart rate values of the QardioArm were compared to those of the BioPatch blood 
pressure device, and the results depicted in Figure 10 reveal that the two devices show 
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similar values and patterns. Differences are most likely due to the fact that the 
QardioArm takes a measurement at a single point in time, making it more susceptible to 
extreme changes and outliers. The QardioArm can be configured to take two or three 
measures and report the average to decrease this variability. 
 
 
Figure 10.  Comparison of One Subject’s Heart Rate Values 
 
3.6 The BrainStation 
 
The BrainStation (Neuroverse, Inc., San Diego, CA) consists of a small electronics 
module and sticker electrodes that attach to the forehead to record a participant’s EEG 
signal, which it transmits to a connected smartphone or tablet via Bluetooth. The data is 
then uploaded to a cloud server for further analysis. The BrainStation is not completely 
waterproof, but utilizes gold-plated electrodes embedded in a Tegaderm film to obtain 
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clean EEG data [40]. An additional Tegaderm patch is applied to the device to protect it 
from water during float sessions. 
 
Since the BrainStation was discovered at the end of this research, only initial usability 
tests were conducted. The device was tested with 5 subjects while floating for 60 to 90 
minutes. Initial testing verified that the Tegaderm protected the device and that EEG 
was recorded throughout the float sessions without signal loss while subjects were fully 
immersed in the float environment with ears under water. Figure 11 depicts an example 
of the EEG data collected during a 90-minute float. 
 
 
Figure 11.  BrainStation EEG Data 
 
3.7 Rejected Devices 
 
Other biosensors initially selected for this research did not pass general usability tests. 
The following subsections describe these devices and the limitations that eliminated 
them from being used in float research. 
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3.7.1 The EQ02 LifeMonitor 
 
The EQ02 LifeMonitor (Equivital, Inc., Cambridge, UK) was the original choice to 
obtain ECG and respiration data. This device also records body temperature, skin 
conductance, and acceleration. It has been used to monitor military performance [13], to 
acquire real-time data for preventive medicine [14], and to analyze physiological 
changes during high-altitude parachute jumps [15]. The LifeMonitor is composed of a 
belt containing embedded electrodes, a string gage, and sensors connected to a Sensor 
Electronics Module (SEM) for mobile monitoring. The system was advertised as 
waterproof and capable of transmitting data in real time. 
 
To obtain clean ECG signals free of noise in the float environment, the LifeMonitor’s 
electrodes must be isolated from the salt solution as much as possible. To this end, 
protective gaskets were fashioned out of silicone putty and placed around the electrodes 
as shown in Figure 12. The putty creates a watertight seal between the body and the 
electrodes, and electrode gel was applied to the electrodes to improve signal strength. 
 
      
Figure 12.  Silicone Putty Gaskets to Protect Electrodes 
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To test this solution, 5 participants floated for 60-minute sessions while wearing the 
LifeMonitor. Initially, two of the participants soaked the electrodes upon entering the 
tank, causing complete loss of the ECG signal. After training individuals to carefully 
enter the tank, three were able to keep chest electrodes relatively dry. Even in these 
situations, the signal became attenuated as more salt water saturated the fabric of the 
chest strap and eventually the electrodes. At the end of most sessions, the ECG signal 
was too weak to accurately calculate heart rates. 
 
To determine breathing measurement accuracy, the Equivital LifeMonitor was tested in 
a reclined chair and in the float tank with three subjects. For each test, participants were 
asked to match their breathing to the rhythm of a metronome. On one tone the 
participant was instructed to inhale, and on the next he or she was instructed to exhale.  
The LifeMonitor breathing rate measurements were then compared to the expected 
breathing rates to determine the accuracy. Results showed that Equivital calculations are 
accurate when participants breath between 6 and 25 breaths per minute. Outside this 
range, participants have difficulty maintaining the prescribed rate, making it difficult to 
determine whether the LifeMonitor is reporting incorrect values or the participants are 
breathing at the wrong rates. Table 2 displays the results of a participant breathing to the 
beat of a metronome at different rates for three-minute periods during a float session. 
As can be seen, breathing rates below six breaths per minute do not match the 
metronome rates. Since normal resting rates vary from 12 to 25 breaths per minute, this 
limitation should not be a problem in most experiments. 
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Table 2.  LifeMonitor Breathing Rates while Floating 
Time Elapsed 
(Seconds) Average Breathing Rate (Breaths per Minute) 
30 9.95 7.45 7.30 5.15 3.00 
60 10.15 8.45 7.50 4.00 5.00 
90 9.90 8.45 5.95 4.50 4.50 
120 10.00 7.25 5.50 7.30 2.75 
150 9.90 8.15 5.65 8.70 3.65 
180 9.86 8.00 5.96 6.26 3.46 
      
Metronome Rate 
(Beats per Minute) 
10 8 6 4 2 
 
 
Heart rates calculated by the LifeMonitor were also compared to those measured by two 
wireless blood pressure monitors described later. Figure 13 shows that the LifeMonitor 
and Withings device yield similar results, with the exception of three outliers recorded 
by the LifeMonitor. These three extreme measurements reinforce the fact that the salt 




Figure 13.  Heart Rate Comparison for One Subject 
 
Although the LifeMonitor is wireless and accurately measures breathing rates, its 
inability to measure ECG during float sessions makes it unusable for this research. This 
device is better suited for studies examining breathing rates and the associated 
waveforms. 
 
3.7.2 The iHealth and Withings Wireless Blood Pressure Monitors 
 
The iHealth (iHealth Labs, Inc., Mountain View, CA) and Withings (Withings, Issy-les-
Moulineaux, FR) wireless blood pressure monitors operate similarly to the QardioArm 
but automatically turn off after two to five minutes of not being used. This requires 
measurements to be taken much more frequently during float experiments, which is 
more invasive and disruptive to subjects. In contrast to the QardioArm and Withings 
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devices, the iHealth blood pressure monitor does not use Bluetooth Smart. The older 
version of Bluetooth prevents it from maintaining a connection during the float 
sessions, so it was quickly discarded in this work.  
 
The accuracy of the Withings wireless blood pressure monitor was previously validated 
in [18], so this study tested the device to evaluate whether or not it could collect data 
during 60-minute float sessions without loss of connection or automatically turning off. 
During these tests, participants were asked to float with the blood pressure device and 
LimbO cast protector while blood pressure and heart rate were measured at four-minute 
intervals. Since the Withings device turns off after 2 minutes of non-use, the device was 
triggered from a tablet in 2-minute intervals. For every other trigger, the test was 
manually canceled from the tablet before the blood pressure cuff began inflating and 
interrupting the participant. Using this method, data was collected for the full duration 
of the float sessions, but the repeated triggering of the device was tedious and 
cumbersome to the experimenter. 
 
Another drawback of the Withings device is its size. Compared to the QardioArm, it is 
much larger and more difficult to fit inside the LimbO without it applying additional 
pressure to a subject’s arm. Due to this and the quick shutoff timer, the Withings device 





3.7.3 The X4 Sleep Profiler 
 
For collecting EEG data, the X4 Sleep Profiler (Advanced Brain Monitoring, Inc., 
Carlsbad, CA) was initially chosen. Because Advanced Brain Monitoring specifically 
modified this device for float environments, initial alterations were not necessary. The 
X4 has an electronics module for data storage and transmission. The module is attached 
to a band with three electrodes, and the electrodes are placed on a participant’s forehead 
during a float session. Although other EEG devices on the market include an additional 
number of electrodes, the technology fails to maintain a watertight seal and prevent 
signal loss. The X4 is water-resistant and can be configured to transmit data wirelessly 
in real-time. 
 
The accuracy of the X4 in dry environments was validated in [16] and [17]; therefore, 
only the device’s ability to operate in the float environment and avoid signal loss was 
evaluated. The device was tested with and without a head pillow. The head pillow kept 
the participant’s head and the X4 out of the water, resulting in a protected device. 
Without the use of a head pillow, water damaged the device on two occasions and 
significant signal loss occurred. Few tests provided usable data without the use of a 
head pillow. Unfortunately, even with the head pillow most participants could not keep 
salt water from reaching the electrodes on their foreheads. This resulted in noisy EEG 
signals as illustrated in Figure 14. Since more than 50% of experiments failed to yield 




Figure 14.  Noisy EEG Data from the X4 Sleep Profiler 
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Chapter 4: Instrumentation Setup 
 
Biosensors validated in the previous chapter can be used individually or collectively in 
float research. The following subsections describe protocols for both use cases and 
examine the validity of comparing data from separate devices to identify common 
events. 
 
4.1 Overall Setup 
 
As described before, the Kinect observes participants from above the float tanks. It can 
either be mounted to the ceiling of the room or the ceiling of the enclosed tank. The 
main limitation that dictates the Kinect’s placement is its field of view (FOV). If a 
participant does not fully fit in the FOV, joint points outside the FOV are often 
displayed with jitter, which leads to false positives when counting joint movements. For 
this reason, the Kinect must be placed high enough above the float tank to ensure a 
sufficiently wide FOV. 
 
According to [41], the Kinect’s FOV is 43o vertical by 57o horizontal. Since the float 
tanks are approximately 8 ft. in diameter, the smaller of the two viewing angles requires 
the Kinect to be placed 10.155 ft. feet above the surface of the water for the FOV to 
encompass the entire tank and participant. If the Kinect cannot be placed this high, as is 
the case with the enclosed tank, then joint points out of view must be estimated and 
filtered in order to remove noise and jitter. Another option is to switch the Kinect to 
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seated mode. This mode tracks only upper body joints and reduces the required height 
to 6.446 ft. 
 
The GENEActiv Original accelerometers come with straps so that they can be easily 
attached to the wrists or ankles. The straps can also be removed so that the device can 
be attached to other areas of the body such as the chest or hips. As shown in Figure 15, 
the pins of the device face the ground in order to correctly orient the xyz-directions. The 
only time this is different is when the accelerometer is placed on the left wrist. In this 
position, the pins should face upward to help differentiate the left wrist from the right 
wrist. Any number of GENEActiv accelerometers can be used to track movement and 
activity, but the level of invasiveness increases with each added device. For this work, 




Figure 15.  GENEActiv Accelerometer Placement [42] 
 
The packaging of the BioPatch instructs users to place the device on the chest above the 
sternum. Although the BioPatch successfully records ECG in other positions, it usually 
fails to capture a valid breathing waveform. Placing the device above the sternum 
ensures accurate collection of ECG and breathing waveforms while also preventing the 
device from being submerged in water. 
 
To validate the recommended placement, 21 subjects wore the device above the 
sternum for 2 90-minute float sessions each. One session was in the enclosed tank while 
the other was in a reclining chair. As described earlier, the BioPatch records a heart rate 
confidence value to characterize the signal-to-noise ratio of the ECG signal. It also 
produces a breathing rate confidence value, and the averages of these values throughout 
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the float session are depicted in Figure 16 and Figure 17. As can be seen, the average 
heart rate and breathing rate confidence values are always higher than 80, except when 
the subjects are initially entering the tank or getting seated in the recliner. The BioPatch 
manual states that heart rate can be accurately calculated as long as the confidence value 
is above 20 [43], and this threshold is maintained for all float sessions except four. In 
these sessions, there was no major difference between floating in the enclosed tank and 
sitting in the recliner, which suggested that the float environment was not the source of 
the noise. Even in these cases, the ECG signal was clean enough to visually identify key 
components of the waveforms. These results verified that placing the BioPatch above 
the sternum ensures successful collection of ECG and breathing waveforms. 
 
 




Figure 17.  Average Breathing Rate Confidence for 42 Float Sessions 
 
As recommended by most physicians and the provided user manual [44], the 
QardioArm blood pressure monitor is placed on the left arm at least an inch above the 
elbow. This position guarantees that the device is at the same height as the heart, 
especially when participants are floating in a supine position. Using the device on the 
left arm only for all participants removes the need to correct for lateral differences and 
simplifies data analysis. 
 
The BrainStation is always placed on the forehead. It is positioned as close to the 
eyebrows as possible to avoid contact with the salt solution in the tanks. This is the 
intended placement and allows collection of frontal EEG. 
 
These devices can be used separately to study one variable at a time or collectively to 
examine common effects and relationships between variables. Regardless of the use 
case, the placement of each device is the same. The main factor to consider when using 
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multiple devices is whether or not the participant is being removed from the float 
experience. In an experiment involving 21 subjects floating with the Kinect, 
GENEActiv accelerometers, and Biopatch, most people reported a decreased sense of 
relaxation compared to floating without any devices. For this reason, it is suggested to 
determine the level of invasiveness of devices before using them in a study. The overall 
setup of the biosensors is displayed in Figure 18. 
 
 
Figure 18.  Overall Setup of Biosensors 
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4.2 Time Sync Evaluation 
 
The following subsections detail the time synchronization protocols employed when 
using multiple devices simultaneously. For devices that require greater precision in 
timing, more advanced methods are developed and tested. 
 
4.2.1 Time Synchronization Protocol 
 
Table 3 contains the physiological variables and waveforms examined in this study 
along with the frequencies at which they are sampled. As can be seen, the fast-changing 
waveforms are sampled at higher frequencies and then used to calculate metrics 
reported at lower frequencies. These slower-changing metrics do not usually require 
timing precision to the millisecond. For instance, there is no need to determine the exact 
millisecond that arm movement began and match it to the nearest R-peak in an ECG 
waveform. For these slower-changing variables, a simple protocol was developed to 









Table 3.  Biosensor Variables and their Frequencies 
Device Measure Frequency 
Kinect Joint Positions 30 FPS 
GENEActiv Accelerometer Acceleration 100 Hz 
Sum of Vector Magnitudes 1 Hz 
QardioArm Blood Pressure > 1 per Minute 
BrainStation EEG 250 Hz 
BioPatch 
ECG 250 or 1000 Hz 
Breathing Waveform 25 Hz 
Acceleration 100 Hz 
Heart Rate 1 Hz 
Heart Rate Variability 1 Hz 
Heart Rate Confidence 1 Hz 
Breathing Rate 1 Hz 
Breathing Rate Confidence 1 Hz 
Activity 1 Hz 
Posture 1 Hz 
 
 
The computers used in this thesis are connected to a Network Time Protocol (NTP) 
server, and the networked computers automatically synchronize their clocks to match 
the time of the NTP server. The BioPatch and GENEActiv accelerometers sync their 
clocks to whichever computer they are connected to, so this protocol requires that both 
devices be synchronized to the same computer prior to each float session. Skeleton joint 
points from the Kinect are time stamped with the time of the local computer, so it is 
mandatory that the Kinect be connected to the same computer that is used to 
synchronize the BioPatch and GENEActiv devices. The QardioArm and BrainStation 
timestamp each of their measurements using the smart phone or tablet to which they are 
connected, and these clocks should closely match the NTP server since they also sync to 
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an NTP server via WiFi or to a cellular tower. Syncing each clock to an NTP server or 
cellular tower in this way ensures similar timestamps between the BioPatch, 
QardioArm, BrainStation, GENEActiv accelerometers, and Kinect. 
 
To illustrate the usefulness of this protocol, 15 subjects participated in 2 float sessions 
each while wearing the BioPatch and GENEActiv accelerometers as stated in Chapter 3. 
In this experiment, participants were asked to stand for a three-minute baseline test 
before entering the float tank or sitting in the recliner. Throughout the remainder of the 
experiment, participants were led through various heartbeat counting tasks and asked to 
grab and discard an item used for a few of the tasks until the end of the test. The timings 
of these events are marked on the graphs of Figure 19.  
 
The lower graph of Figure 19 reveals that the GENEActiv accelerometers show 
significant amounts of acceleration at the times when participants transition from 
standing to lying down and when they are required to grab or discard the heartbeat-
counting object. Comparing this data to the upper graph of Figure 19 shows that quick 
heart rate changes typically induced by movement or changes of position occur at the 
same moments when the accelerometers show significant movement. From this it is 
apparent that the timestamps of the accelerometers are sufficiently synchronized with 
those of the BioPatch and that comparisons can be made between the time courses of 




Figure 19.  Comparing Average Heart Rate with One Subject’s Accelerometer Data 
 
Additionally, the timestamps of the BioPatch’s posture data can be used to determine 
when a participant lays down in the float tank or sits in the chair. Figure 20 is a plot of 
the posture of two participants, one in each scenario. The data reveals that the 
participant getting into the float tank required more time to transition to a supine 
position than the participant that sat in the recliner, which makes sense logically. The 
timestamps can be analyzed to determine when each participant actually began his or 




Figure 20.  One Subject’s Posture Changes during Two Float Sessions 
 
Many of the devices mark data points with millisecond time stamps, but this can be 
misleading. The real-time clocks of these devices only keep track of time to the second, 
and milliseconds are counted up from zero each time a device is turned on. The 
implication is that timestamps can contain an inherent difference between their time and 
the computer’s time. This difference can vary anywhere from 1 to 999ms as explained 
in the next subsection. Since most variables do not change drastically from second to 
second, the effect of this difference is small. If devices require precision greater than 
one second, more complex synchronization methods must be devised. 
 
4.2.2 RR-Interval-Based Synchronization of ECG Waveforms 
 
Float research sometimes examines reaction times and biofeedback by comparing 
variables from separate devices. One such experiment studies subjects’ ability to sense 
their own heartbeat and requires a response each time a heartbeat is felt. In order to 
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calculate reaction times between the R-peak of the heartbeat and the response of the 
subject, millisecond time precision is required.  
 
To determine whether or not this requirement could be met by the previously described 
protocol, ECG waveforms were simultaneously recorded using the BioPatch and a 
BIOPAC ECG device. The BIOPAC system can be configured to record data at various 
sampling rates and serves as an industry leader for accurately collecting physiological 
data. After collecting and plotting multiple recordings, it was found that the waveforms 
of the two devices never align in time as can be seen in Figure 21. This held true for 10 
recordings, and in each one, the distance between corresponding R-peaks was different. 
To determine if the variable misalignment was at least constant within a test, each R-
peak from the BioPatch waveform was paired to the closest R-peak of the BIOPAC 
waveform, and the distance in samples between each pair was calculated. The standard 
deviation of each test’s distances was always greater than 50ms. This revealed that the 
time synchronization protocol was not sufficient for providing millisecond precision 
and suggested that the BioPatch clock may have an internal drift. These findings led to a 
discussion with the manufacturer of the BioPatch, and key details of the BioPatch’s 




Figure 21.  Simultaneously Recorded ECG Waveforms 
 
The real-time clock of the BioPatch is synchronized to a computer anytime it is attached 
via USB, but it only tracks time to the second. This means that if the local computer 
time is 12:03:42.347, the clock of the BioPatch will be set to 12:03:42, and the 347 
milliseconds will be truncated. This creates an initial constant offset of 347 
milliseconds, and this offset is different each time the device is connected to the 
computer. The offset can vary anywhere between 0 and 999ms based on the local time 
of the computer when synchronization occurs. Additionally, another offset is introduced 
when the BioPatch is powered on. Since the real-time clock only keeps time to the 
second, the BioPatch software begins counting milliseconds starting at zero only when 
the device is turned on in order to timestamp data points with millisecond resolution. 
This means that if the device was turned on at 12:05:16.893, the BioPatch clock starts at 
12:05:16.000, and the software counts up one millisecond at a time. This creates another 
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constant offset of 893ms, creating a total offset of 1240ms. As before, the second offset 
can vary anywhere between 0 and 999ms based on when the BioPatch is powered on, 
meaning the total offset can vary between 0 and 1998ms. This explains why 
simultaneous recordings result in signals with variable offsets. 
 
Although the BioPatch maintains a wireless connection via Bluetooth, it is unable to 
utilize this connection to resynchronize its clock. Since there is no way to sync or probe 
the BioPatch’s clock and determine its time until after the device is turned off and data 
is downloaded, the offset has to be corrected in post processing. Usually such time 
synchronization is achieved in the BIOPAC system by injecting a digital signal into the 
data streams and using the start of the signal as time zero. In the case of the BioPatch 
and BIOPAC recordings, they already contain a common signal, the ECG waveform, 
but the morphologies of these two waveforms differ greatly and make it difficult to 
identify the same heartbeat in each signal. Simply shifting the waveforms left and right 
to align nearby heartbeats failed to align the signals as illustrated in the plots of Figure 
22. After two shifts of the waveforms, the distances between closest R-peaks were 
calculated by subtracting the locations of the BIOPAC R-peaks from those of the 
BioPatch R-peaks. For the first shift, the mean difference was -11ms with a standard 
deviation of 98ms. The second test yielded a mean difference of 10ms and a standard 




    
Figure 22.  ECG Waveforms Shifted to Align R-peaks 
 
A drift in the real-time clock of the BioPatch would result in inaccurate RR-intervals, 
which are the distances between consecutive R-peaks in an ECG waveform. To 
examine this, the RR-intervals of each waveform were plotted, and the results are 
displayed in Figure 23. The figure reveals that the two RR-interval plots are nearly 
identical, but one is shifted by a specific number of samples. This verified that the 
BioPatch was recording without any drift in its real-time clock, and the shift revealed 
how to correctly align the two waveforms. If the number of samples between 
corresponding RR-interval plot points is three, this means that the distance between the 
first and second R-peaks of one waveform are equal to the distance between the fourth 
and fifth R-peaks of the other waveform. Thus, the first R-peak of the first waveform 
corresponds to the fourth R-peak of the second waveform. Due to the variation that 
exists in the offset of the BioPatch’s clock, the peaks that correspond to each other can 
vary for each recording. The RR-interval plots provide information about which 




Figure 23.  RR-interval Plots 
 
Using this information, a simple method to calculate the shift between RR-interval plots 
was developed and used to determine the number of samples to shift one waveform to 
align it with the other. For simultaneously recorded BioPatch and BIOPAC ECG 
waveforms, the RR-intervals of each signal are plotted together, and the graph is split 
into windows of 20 samples each as shown in Figure 23. The max value of each plot in 
each window is found, and difference between max points is calculated. Taking the 
mode of the differences of each window yields the RR-interval plot shift value. Using 
multiple windows reduces error caused by slight differences in RR-interval values. 
Once the shift value is determined, it is used to correctly match the R-peaks of one 
waveform to the R-peaks of the other, and the distance between matched peaks is 
calculated. The mean distance is the offset of the BioPatch’s clock and is used to shift 
one waveform to align with the other as displayed in Figure 24. For simplicity, the shift 
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is achieved in this plot by appending the correct number of samples with a value of zero 
to the beginning of the waveform being shifted. In this way, timestamps of the BioPatch 
can be corrected and used to accurately calculate response times in float studies 
involving heartbeat perception. 
 
 
Figure 24.  Synchronized Waveforms Using RR-Interval-Based Method 
 
This method was validated in 6 90-minute simultaneous recordings. After shifting the 
waveforms of each test to align properly, the mean, standard deviation, maximum, and 
minimum of differences were calculated for corresponding R-peaks, and their values are 
displayed in Table 4. As can be seen, each shift resulted in a mean difference between 
corresponding R-peaks of less than 0.3ms with standard deviation below 2ms, which 
verified the accuracy of the method. 
 
52 
Table 4.  Delay Stats for Matched Waveforms 
Delay (ms) Test 1 Test 2 Test 3 Test 4 Test 5 Test 6 
Mean -0.205 0.168 0.123 0.137 0.149 0.271 
SD 1.367 1.502 1.374 3.183 1.749 1.985 
Max 4 5 6 27 6 56 
Min -4 -5 -5 -136 -7 -9 
 
 
The drawback of this method is that it requires simultaneous recordings to be obtained 
before each experiment. This adds to the total experiment time and to the overall 
analysis process. For these reasons, an additional method was developed and validated 
by comparing it to the RR-interval-based method. 
 
4.2.3 Parallel-Port-Based Synchronization of ECG Waveforms 
 
As stated in the previous subsection, the BIOPAC system uses a digital signal to 
synchronize simultaneously collected data. A parallel port produces this digital signal, 
and a time stamp can be recorded when the signal is injected. This time stamp can be 
compared to the time stamp of a device that receives the signal to determine the offset 
of the device’s clock. Using the parallel port, a prototype was designed to inject a 
digital signal into the ECG waveform of the BioPatch. 
 
The prototype depicted in Figure 25 consists of ECG electrodes, wire connectors, and 
the parallel port and its connector. The wire connectors run from pins of the parallel 
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port connector to the ECG electrodes to inject the digital signal into the BioPatch when 
it is connected to the electrodes. The computer saves the time at which the signal is 
injected, and this time stamp is compared to the time stamp of the BioPatch to 
determine the offset. 
 
 
Figure 25.  Parallel Port Prototype for Synchronization 
 
This method was tested by powering on the BioPatch device, injecting the 5V digital 
signal into its ECG waveform, and then recording ECG simultaneously with the 
BioPatch and BIOPAC devices. After data collection, the portion of the BioPatch ECG 
waveform containing the digital signal was used to determine the offset. As Figure 26 
reveals, injection of the digital signal drives the ECG waveform to a max value. The 
time stamp that matches the sample with this max value was identified and compared to 
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the time stamp of the digital signal to calculate an offset value of 400ms. The offset was 
then used to correct the time stamps of the BioPatch’s ECG waveform. 
 
 
Figure 26.  ECG Waveform with Digital Signal 
 
The RR-interval-based method was also used for this test and resulted in an offset time 
of 398ms. Using the offsets, the waveforms were plotted for each method, and distances 
between corresponding R-peaks were calculated as before. Figure 27 depicts the 
synchronized waveforms. The mean difference in R-peaks was 0.307ms with a standard 
deviation of 0.930ms for the parallel-port-based method as compared to a mean of 
0.284ms with standard deviation of 0.914ms for the RR-interval-based method. 
Although the parallel-port-based method yields slightly less accurate results, it 
ultimately provides a way to synchronize the BioPatch clock without requiring 
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simultaneous ECG recordings. Either of these methods can be used to synchronize the 
BioPatch’s clock as the researcher sees fit. 
 
 
Figure 27.  Synchronized Waveforms Using Parallel-Port-Based Method 
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Chapter 5: Using a Neural Network to Calculate Cardiac Metrics 
 
Cardiac metrics such as heart rate and heart rate variability (HRV) often provide 
information about the circulatory, respiratory, and nervous systems [29], [45]. 
Unfortunately, the BioPatch’s cardiac algorithms lose some of this data. These 
algorithms filter and smooth the ECG signal and calculate variables using methods that 
fail to characterize respiratory-linked variability and cardiac vagal control. In order to 
regain this information, this chapter develops an artificial neural network (ANN) to 
automatically detect the R-peaks in raw ECG signals. These R-peaks are then used to 
illustrate how researchers can calculate heart rate and HRV using methods that yield the 
most useful information for float research. 
 
5.1 A Neural Network for Automatic Detection of R-peaks 
 
ECG signals represent the electrical activity of the heart and contain a repeating P-
wave, QRS complex, and T-wave as shown in Figure 28. The peak of the QRS complex 
is known as the R-peak and is used to calculate heart rate, HRV, and RR intervals. The 
shape and amplitude of each wave or complex in the ECG signal depends on electrode 
placement, patient physiology, and noise. Variation in these parameters makes 
automatic R-peak detection difficult.  
 
Various algorithms have been developed to automatically identify cardiac events. In 
[46], the authors build upon common thresholding techniques to create an adaptive 
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double threshold method for R-peak detection in real time, and the authors of [47] use 
the Pan-Tompkins algorithm, which also employs multiple thresholds, combined with a 
wavelet transform to increase detection accuracy. Since these methods rely heavily on 
amplitude thresholds, they often perform poorly in the presence of noise and artifacts. 
 
 
Figure 28.  Components of an ECG Signal 
 
Other studies have shown that neural networks deal well with noise and baseline drift. 
Szilagyi compared neural-network-based adaptive filtering and the wavelet transform to 
detect R-peaks [48]. The wavelet transform magnifies QRS complexes at finer scales, 
while the neural network removes noise via whitening. Both methods use a thresholding 
technique to find R-peaks in the final signal, and it was shown that neural networks 
usually outperform wavelet-based methods. A more complex adaptive filter is presented 
in [49]. This method uses two neural networks; the first acts as an adaptive filter to 
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whiten the ECG signal, and the second is used in a matched filter that outputs a signal 
with well-defined QRS complexes. Thresholding is performed on this final signal to 
detect R-peaks. This type of filtering requires a large amount of training data. 
 
A simpler neural network presented in [50] is a two-layer tan-sigmoid/linear network. It 
uses amplitude, differentiation, duration, RR interval, a zero-crossing flag, and a first-
element flag as inputs and updates weights via back propagation. It outputs a 1 for an R-
peak and a 0 for not an R-peak instead of filtering the ECG signal. It is applied in real-
time and provides an accurate method of detecting R-peaks.  
 
Since the literature revealed neural networks to be effective in dealing with nonlinear 
background noise and baseline drift, this study designed one to automatically detect R-
peaks. The following subsections detail the neural network’s design and the results of 
testing it with ECG signals collected during float experiments. 
 
5.1.1 Network Design 
 
Figure 29 illustrates the structure of the designed neural network. The hidden layer uses 
a tan-sigmoid function to model nonlinear data, while the output layer is linear. There 
are 4 inputs to the system and 9 hidden neurons. The number of hidden neurons was 
determined using the 2m + 1 rule, where m is the number of normalized inputs when the 
network has only one hidden layer [51].  
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The inputs of the network are amplitude, RR interval, duration above a threshold, and a 
first-element flag. The network in [50] has two additional inputs, differentiation and a 
zero-crossing flag. The differentiation did not seem to contribute much to the network’s 
ability to distinguish between peaks in this work, and using the network in post-
processing removed the need to segment the ECG signal and check if end points were 
zero-crossing points. Peaks are provided to the network using a generic peak-detection 
algorithm that finds max points preceded by points below a specified threshold [52]. 




Figure 29.  Neural Network Structure 
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Each input and bias of a network layer is connected to each neuron of the next layer, 
and each connection has a corresponding weight. The notation wij(n) represents the 
weight in layer n of input i to neuron j of the next layer. These weights are updated via 
standard back-propagation with an added momentum variable to help avoid local 
minimums. The output neuron simply sums the weighted inputs of the previous layer, 
and a threshold of 0.5 is used to output a 1 for R-peaks and a 0 for all other points. 
 
To obtain ECG data to train and test the network, 21 subjects spent 1 session in the float 
tank and another in a reclining chair while wearing the BioPatch. The sessions were 
each 90 minutes long, but 40 minutes in the middle were allotted as a rest period with 
no activity. These 40-minute periods were used to collect data to train and test the 
neural net. From the resulting 42 ECG signals, 10 were chosen for training, 10 for 
validation, and 15 for testing. Signals with greater amounts of noise and baseline drift 
were placed in the testing set to determine the limitations of the neural network. For 
each of the ECG signals, the first 10 seconds were used for training and validation. 
Initial testing also used the first 10 seconds of the signals, but later tests used the full 40 
minutes to test the network’s ability to work with data recorded for longer periods of 
time. 
 
5.1.2 Training and Validation 
 
The network was trained using 10 10-second signals recorded while participants were in 
the float tank or reclining chair. Each point in the signals was manually labeled as either 
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a 1 for an R-peak or a 0 for not an R-peak. Using the peak-detection algorithm with a 
low threshold value, peaks were detected, and then their amplitude, RR interval, 
duration, and first-element flag were determined. The RR interval is defined as the 
interval from the current peak to the last R-peak. The duration is calculated as the 
distance between the points to the left and right of the current peak that are half the 
peak’s amplitude. The first-element flag is a 1 if the detected peak is the first R-peak or 
any peak that occurs before the first R-peak and a 0 otherwise.  
 
After all the inputs are extracted for each detected peak in each signal, they are 
normalized. This prevents large values from saturating the neurons. There were 
approximately 629 example peaks, and the network was given the inputs and target 
output of each for training. The network randomly selects examples and updates its 
weights using back-propagation of the network error. After training the network for 800 
epochs, the weights that achieved the lowest mean squared error (MSE) were saved and 
used with the validation and test datasets. 
 
A validation dataset of 10 additional 10-second signals was used to determine what 
threshold value to use with the peak-detection function during testing. This function 
takes in a threshold value as input and returns peaks that have a max value preceded by 
a value lower than the threshold. The threshold was set to a very low value to obtain 
many peaks for training data, but its value should be tested to optimize accuracy during 
testing. Using a validation dataset to select the threshold serves this need while 
preventing contamination of the test dataset. To measure the results of each threshold 
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value, accuracy was defined in terms of sensitivity and positive predictivity. These 
measures prevent false positives from resulting in traditional accuracy scores greater 
than 100%. Sensitivity and positive predictivity are defined as 
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =    !"
!"!!"
             (5.1) 
and 
𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒  𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =    !"
!"!!"
,   (5.2) 
where TP is the number of true positives, FN is the number of false negatives, and FP is 
the number of false positives. 
 
The threshold was varied from 0.1% to 100% of the max amplitude of the signal in 
increments of 0.1%, and the average sensitivity and positive predictivity were 
calculated for each threshold. As shown in Figure 30, both the sensitivity and positive 
predictivity have max values from threshold values of 5% to 10%. At about 15%, both 
values drop and plateau until 75% for sensitivity and 87% for predictivity, and then they 
fall rapidly with further increases in the threshold value. The high accuracy at such low 
threshold values is most likely do to the fact that many of the BioPatch ECG waveforms 
contain large T-waves and very small R-peaks. To ensure detection of these low-
amplitude R-peaks, the threshold was set to 7.5% of the maximum amplitude for the test 
dataset. This low threshold also ensures that the neural network’s ability to distinguish 





Figure 30.  Validation Results of Neural Network 
 
5.1.3 Test Method and Results 
 
The neural network was first tested in 15 experiments, each with a different 10-second 
signal. Each of the signals contained varying amounts of noise and artifacts and 
presented different challenges for detection. Figure 31 illustrates the method used for 
testing new signals.  
 
First, the algorithm loads an ECG signal and determines its max amplitude. Using 7.5% 
of the max amplitude as a threshold, the peak-detection algorithm identifies peaks in the 
ECG signal. For each detected peak, the input features are calculated and saved. 
Initially, only the first detected peak has a 1 for the first-element flag feature, and the 
RR interval of each peak is the distance between it and the previous peak. For the first 
peak, the RR interval is simply the distance from the peak to the first point in the signal. 
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All of the input features are normalized using the mean and standard deviation of the 
training data, and then the first peak and its features are given to the neural network.  
 
The neural network then uses the saved weights from training to determine whether the 
peak is an R-peak or not. If the first peak is not an R-peak, the first-element flag of the 
next peak is changed to a 1. This is repeated until the first R-peak is found. When an R-
peak is successfully found, the RR interval of the next peak is updated to reflect its 
distance from this R-peak. This ensures that accurate RR intervals are calculated. Each 
time an input is changed, it is normalized before being given to the network. This 
process is repeated until there are no more detected peaks in a signal. After the last peak 
has been classified, the sensitivity and positive predictivity of the experiment is 
calculated, and then the next signal is loaded. Once all the signals have been tested, the 




Figure 31.  Neural Network Flowchart 
 
The average sensitivity and positive predictivity were 67.0% and 82.8%, respectively, 
and the results for each of the 15 experiments are displayed in Table 5. The results 
reveal that the neural network is very effective with certain signals while ineffective 
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with others. When the R-peaks are dominant, as in Figure 32, the network easily detects 
them. With significant baseline drift, the network missed an R-peak but was able to 
recover as seen in Figure 33. Figure 34 illustrates that when the R-peak is very low in 
amplitude and the T-wave resembles the R-peak, the network confuses each T-wave for 
an R-peak. Arguably, these can still be used to calculate accurate heart rates and HRV. 
In the worst case, the R-peak is low and the T-wave does not resemble an R-peak. This 
results in the network not detecting any R-peaks at all as shown in Figure 35. These 
results imply that the current network is best suited for cleaner ECG signals and can 
handle moderate noise and baseline drift. With additional training data, the network can 
be applied to more signals with greater variety and noise. 
 
Table 5.  Accuracy of Neural Network 
Experiment Number Number of R-Peaks Sensitivity Positive Predictivity 
1 10 100% 50% 
2 14 85.7% 100% 
3 14 85.7% 100% 
4 11 9.1% 100% 
5 16 0% 0% 
6 12 100% 100% 
7 13 92.3% 92.3% 
8 12 100% 100% 
9 11 45.5% 100% 
10 11 0% 0% 
11 13 100% 100% 
12 13 76.9% 100% 
13 12 100% 100% 
14 11 100% 100% 





Figure 32.  Clean ECG in Experiment 8 
 
 
Figure 33.  Baseline Drift in Experiment 7 
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Figure 34.  T-wave Confusion in Experiment 5 
 
 
Figure 35.  No Detections in Experiment 10 
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Since the ultimate goal of the network is to detect R-peaks for the calculation of heart 
rate and HRV from ECG signals recorded during float sessions, the network was tested 
on 4 of the 40-minute signals. One of these signals was obtained from the training set, 
two from the validation set, and one from the testing set. This tested the network’s 
ability to work with both familiar and unfamiliar data for longer periods of time. 
 
The results of testing these four signals are displayed in Table 6. As can be seen, there 
are no more than 6 missed detections out of more than 2100 peaks. One of the signals 
contained significant baseline drift, which resulted in 45 false detections. Since heart 
rate and HRV values are usually averaged over large windows containing many peaks, 
these missed and false detections should have minor effects on the calculated cardiac 
metrics. The next section uses these detected R-peaks to determine such metrics and 
proves that the network’s error has little effect on the end results. 
 
Table 6.  Results of Testing 40-minute Signals 
Experiment Number Number of Peaks Missed Detections False Detections 
1 3052 0 2 
2 2999 1 10 
3 2189 1 2 






5.2 Calculation of Cardiac Metrics 
 
The BioPatch algorithms use unknown smoothing and filtering techniques before 
calculating heart rate and HRV. This often removes variability and other information. 
Using the neural network presented in the previous section, R-peaks can be detected and 
used to calculate cardiac metrics without the loss of data. This provides full access to 
the data collected in float research. 
 
5.2.1 Heart Rate 
 
According to the BioPatch’s log description manual, ECG is filtered and smoothed to 
account for missed R-peak detections, and heart rate is calculated using a moving 
window of 15 seconds [43]. These processes yield heart rate values resembling average 
heart rate and suppress variability. Since it is more common to calculate heart rate on a 
beat-by-beat basis, R-peaks detected by the neural network can be used to do so without 
losing information via filtering. 
 
Using the 40-minute signal from experiment 1, the heart rate was calculated for each R-
peak by dividing the number of samples in one second by the current peak’s RR 
interval. The results are displayed in Figure 36. The neural network’s two false 
positives result in the two extreme heart rate values shown in the end of the plot, but 
such outliers can be removed. Figure 37 illustrates the heart rate values reported by the 
BioPatch. The BioPatch plot appears to be a smoothed version of the neural network 
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plot, reinforcing the fact that information is lost when smoothing and filtering is used. 
These results demonstrate how the neural network can be used to calculate heart rate 
without losing data. This provides researchers with full access to the data. 
 
 
Figure 36.  Neural Network Heart Rate for One Float Session 
 
 
Figure 37.  BioPatch Heart Rate for One Float Session 
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5.2.2 Heart Rate Variability 
 
As with heart rate, the BioPatch reports HRV once per second using a moving window 
instead of on a beat-by-beat basis. Its algorithm calculates a 300 heartbeat SDNN value, 
which is the standard deviation of RR intervals. Using the neural network’s detected R-
peaks, SDNN can be calculated for each peak instead of each second. Like the 
BioPatch’s algorithm, a 300-heartbeat window is used and moved one peak at a time 
instead of one second at a time. Figures 38 and 39 show the results of calculating 
SDNN using both methods. As before, the BioPatch yields a smoothed version of the 
HRV plot. Using the neural network provides more data.  
 
In addition to calculating HRV using the SDNN method, HRV can also be measured 
using the root mean squared of successive differences (RMSSD). The RMSSD value 
reflects respiratory-linked changes in the heart. Using detected R-peaks, the RMSSD 




Figure 38.  BioPatch SDNN Values for One Float Session 
 
 




Figure 40.  Neural Network RMSSD Values for One Float Session 
 
Although HRV values can be calculated on a second-by-second or beat-by-beat basis, 
the literature recommends either calculating a single value for the entire recording or 
calculating a value for each five-minute period [29]. Using the second method, eight 
SDNN and eight RMSSD values were calculated for the 40-minute recording period 
and are shown in Table 7.  
 
Table 7. Neural Network’s SDNN and RMSSD Values 




2 36.33 16.77 
3 34.11 14.78 
4 34.21 15.92 
5 36.61 19.39 
6 44.19 25.56 
7 35.73 25.58 




Once HRV values are calculated for multiple subjects or sessions, various time-domain 
and frequency-domain analyses can be performed to compare results [29]. The purpose 
of this study is to demonstrate how the neural net provides complete access to cardiac 
metrics, so these analyses are not performed here. Future research can utilize the neural 
net developed in this chapter to analyze the effects that floating has on both heart rate 
and HRV.   
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Chapter 6: Measures of Movement – Stillness and Avoidance 
 
For the first time, flotation researchers can study movement throughout float sessions 
using the Kinect and the accelerometers of the BioPatch and GENEActiv devices. The 
aim of this chapter is to take the beginning steps in analyzing movement data and 
develop metrics to characterize it. Using data from the GENEActiv accelerometers, 
activity thresholds are developed and applied to the BioPatch to provide a measure of 
stillness throughout float sessions. Additionally, a measure of avoidance behavior is 




Although three of the selected biosensors are capable of monitoring movement, it is 
often desirable to use one at a time to reduce overall invasiveness. Since the BioPatch 
does not require use of a foothold system and is placed in a single location on the body, 
it is the optimal choice for monitoring stillness. In order to determine whether or not the 
BioPatch is sufficient for measuring stillness, a receiver operator characteristic (ROC) 
curve analysis was performed using data recorded with the GENEActiv accelerometers. 
 
To collect data, 11 participants floated for 2 90-minute sessions wearing the BioPatch 
and a GENEActiv accelerometer on each wrist. One session was in the float tank, while 
the other was in a reclining chair. After collection, the GENEActiv data was converted 
into one-second epochs. The BioPatch activity data is reported once per second by 
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default. Using the timestamps of each device, the 90-minute sections of data were 
extracted and synchronized in time. 
 
In [26], three thresholds were defined to separate sedentary activities from more than 
sedentary activities using the GENEActiv accelerometers. Since the aim of this 
investigation was to measure whether a person is still or not still, similar binary 
thresholds were desired for the BioPatch. The value used with the GENEActiv devices 
to characterize movement is the gravity-subtracted sum of vector magnitudes and is 
calculated as: 
𝑆𝑉𝑀!" =    [ 𝑥! + 𝑦! + 𝑧!
!
! − 1𝑔]      (6.1) 
with a unit of g-seconds (g·s). After categorizing activity using oxygen uptake values, 
the authors of [26] performed an ROC curve analysis with one-minute epochs and chose 
the thresholds for the left wrist, right wrist, and waist accelerometers to be 217, 386, 
and 77 g·min, respectively. These values can be divided by 60 seconds to obtain 
thresholds applicable to 1-second epochs. This results in values of 1.28, 3.62, and 6.43 
g·s. 
 
Each of these thresholds was applied to the GENEActiv accelerometer data to create 
three ROC curves for the BioPatch. For each second of data, the higher of the two 
values from each GENEActiv accelerometer was compared to the threshold to 
categorize the second as either still or moving. The resulting data was used to determine 
the optimal threshold to use for the BioPatch. 
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The BioPatch reports activity in vector magnitude units (VMU) calculated as: 
𝑉𝑀𝑈 =    (𝑥! + 𝑦! + 𝑧!),     (6.2) 
where x, y, and z are the averages of the three axial acceleration magnitudes over the 
previous one second. The reported values ranged from 0 to 1g in the 90-minute floats. 
ROC curves are produced by incrementing the threshold of a binary classifier and 
plotting the false positive rate (false positives / (false positives + true negatives)) versus 
the true positive rate (true positives / (true positives + false negatives)), so the threshold 
was tested from 0 to 1g in increments of 0.01g. For each threshold, the BioPatch’s 
VMU values were compared to the threshold to categorize each second as still or 
moving. The results were then compared to the GENEActiv classifications to calculate 
the number of true positives, false positives, true negatives, and false negatives. These 
were then used to plot an ROC curve for each of the three tests, and the results are 




Figure 41.  ROC Curves 
 
From the ROC curves of Figure 41, it is apparent that the BioPatch accuracy increases 
with more lenient thresholds placed on the GENEActiv accelerometers. The area under 
the curve (AUC) for GENEActiv thresholds of 1.28, 3.62, and 6.43 g·s is 0.567, 0.784, 
and 0.920, respectively. Optimal thresholds are typically those that maximize the true 
positive rate while minimizing the false positive rate. For the ROC curve with the 
maximum AUC, the first false positive rate with a value below 0.10 is 0.046 and yields 
a true positive rate of 0.742. This occurs at a threshold value of 0.03g. Unfortunately, 
this threshold results in the BioPatch categorizing 4779 more seconds as moving than 
do the GENEActiv accelerometers. At a threshold of 0.06g, the BioPatch reports 
93.93% of the movement time that the accelerometers do, but the true positive rate 
drops to 0.400. 
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As discussed in Chapter 4, the real-time clocks of these devices can have an offset up to 
1998ms. This may cause movement seen in one device to appear later in another device, 
which would result in errors reported during classification. For this reason, it may be 
more appropriate to select thresholds for the BioPatch that maximize the percent of 
movement time found by the GENEActiv accelerometers instead of thresholds that 
correctly label each second of data. Also, since [27] found the GENEActiv cut-points to 
be somewhat inaccurate, further research is needed to validate the thresholds of both the 
BioPatch and GENEActiv accelerometers. 
 
To briefly analyze the types of body movement the GENEActiv accelerometers and 
BioPatch can detect, one subject floated in the float tank wearing all three devices and 
sustained specific body movements for 1.5 minutes each. For each of the body 
movements, the middle one minute of data was extracted for analysis. As before, the 
GENEActiv data was summed to create one-minute epochs, and the BioPatch VMUs 
were averaged over each minute. Since the values of each device have drastically 
different ranges, the BioPatch data was scaled for visualization. The values for each 
device were then plotted together to illustrate the relative levels of activity seen in each 
device for each body movement. The results are displayed in Figure 42, and Table 8 




Figure 42.  Relative Activity Levels of Accelerometers 
 
Table 8. Description of Movement Numbers 
Movement Number Type Distance Speed 

















12 Long Slow 
13 Fast 
14 Left Leg Short Slow 
15 Long Fast 
16 Right Leg Long Slow 
17 Fast 
18 Both Legs Long Slow 
19 Fast 
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As the graph shows, the activity of the left wrist accelerometer increases with larger 
movements and more activity of the left arm. It shows little activity when only the right 
arm is moving, but shows moderate activity when the legs are moving. The same is true 
for the right wrist accelerometer. Interestingly, the BioPatch detects most movement in 
the arms and legs. It does not seem to notice small, light movements of the arms, but it 
detects most movements of the legs. These results suggest that the BioPatch can be used 
to measure stillness during float sessions. More research is needed to determine 




Avoidance behavior was characterized in a brief experiment using the Kinect since 
some float studies seek to examine it in participants exposed to certain stimuli. During 
the float sessions, participants are held in place with the foothold system so that their 
heads remain in the same location. A stimulus can be delivered in various levels of 
intensity to the left, right, or center of the participant’s head. In these tests, researchers 
want to determine if participants exhibit avoidance behavior by moving in the opposite 
direction of stimulus delivery. 
 
Such an experiment is fitting for the Kinect since the foothold system is already 
required. To test the Kinect’s ability to monitor avoidance behavior, a participant 
floated in the tank and moved his head to the left and right after collecting a baseline 
measure of head position. The first of these movements was made by simply rotating 
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the head left and right while keeping the rest of the body still. The second test required 
the participant to move his entire body left and right while keeping his feet on the 
foothold system. With small head movements, the x-coordinate of the head ranged from 
219 to 278 pixels. For large movements, it ranged from 162 to 327 pixels. This 
confirmed that the Kinect can detect both types of head movements, and the reported 
locations can be used to measure avoidance. 
 
One simple measure of avoidance is distance traveled from the center or baseline 
position. The participant was able to move his head left or right 29.5 pixels from the 
center for the experiment with small head movements and 82.5 pixels left and right with 
large movements. Such travel distances can be separated into categories and used to 
define varying levels of avoidance. 
 
Avoidance can also be characterized in degrees shifted away from the centerline. Using 
the neck or waist as a hinge point, the head location can be used to measure how many 
degrees it is away from the centerline. This again can be broken into categories to 
describe multiple levels of avoidance. Since values will vary from person to person 
based on body type, future research should investigate methods to standardize these 
measures across participants. 
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Chapter 7: Conclusion 
 
Float tanks are returning as a form of therapeutic treatment in many recreational and 
healthcare settings. This thesis presented the selection and validation of off-the-shelf 
biosensors to aid researchers and float tank entrepreneurs investigate the effects of this 
novel healthcare environment. Modifications to the selected devices were developed to 
ensure usability in the unique environment created by float tanks, and these 
modifications were tested to determine their effectiveness in protecting the devices and 
minimizing invasiveness. After an initial process of validation, it was determined that 
the modified biosensors could successfully and continually monitor movement, ECG, 
respiration, EEG, and blood pressure during float sessions. 
 
After initial validation, a protocol and two techniques were developed to ensure time 
synchronization between devices. These were tested against an industry-leading 
physiological recording device, and the results verified the effectiveness of the methods 
to ensure accuracy of the biosensors’ timestamps. Additional experiments between 
devices further validated the methods and illustrated how an event can be identified in 
multiple data streams. Additionally, an artificial neural network was designed to 
automatically detect R-peaks in ECG signals. This gives researchers full access to the 
ECG data, enabling them to calculate cardiac metrics as they see fit. Using 
accelerometer data from two devices, optimal cut-points were determined to classify 
movement and establish a measure of stillness for float research. 
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Future work should focus on determining the invasiveness of each biosensor. Such a 
study would reveal which devices or combination of devices remove participants from 
the float experience. Other research could develop more efficient methods of finding R-
peaks in ECG signals. Since the accuracy of automatic detectors can only be calculated 
after collecting ground-truth data, an automated method of annotating R-peaks would 
help provide more training data for a neural network or other machine-learning agents. 
Improvements are also needed to design better algorithms for detecting movement. 
Lastly, data from various sensors should be combined into patient reports. One of the 
goals of float research is to develop treatments for mentally ill patients, and reports 
would empower patients to take ownership of their treatment by tracking their progress. 
 
Float research will also benefit from advancements in industry. Personal health devices 
are becoming more available, but manufacturers need to improve their devices’ abilities 
to synchronize with devices of other companies. This may be solved by utilizing a 
common platform or tool to collect and analyze data from multiple biosensors. 
Allowing users to easily and flexibly insert timestamps into each data stream would also 
aid the synchronization process. Companies designing biosensors specifically for the 
float environment should strive to fully waterproof their devices and limit points of 
entrance by implementing wireless charging and data transmission. Although 
physiological monitoring devices have progressed greatly since flotation research 
began, many tested in this thesis still failed to survive in the float tank’s harsh 
environment. Nevertheless, this work presented the first successful implementation of 
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